The inflammatory caspases: Key players in the host response to pathogenic invasion and sepsis

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4239-4245

  Nadiri, Amal ^a   Wolinski, Melissa K ^b   Saleh, Maya ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 11; CASPASE 12; CASPASE 4; CASPASE 5; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG; VX 765;

CHROMOSOME 11Q; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; PHYLOGENY; PRIORITY JOURNAL; PROTEIN FUNCTION; SEPSIS; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33749131042     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4239     Document Type: Short Survey

References (92)

1. Nicholson, D. W. 1999. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6: 1028-1042.
2. Lamkanfi, M., W. Declercq, M. Kalai, X. Saelens, and P. Vandenabeele. 2002. Alice in caspase land: a phylogenetic analysis of caspases from worm to man. Cell Death Differ. 9: 358-361.
3. Salmena, L., B. Lemmers, A. Hakem, E. Matysiak-Zablocki, K. Murakami, P. Y. Au, D. M. Betty, L. Tamblyn, A. Shehabeldin, E. Migon, et al. 2003. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17: 883-895.
4. Chun, H. J., L. Zheng, M. Ahmad, J. Wang, C. K. Speirs, R. M. Siegel, J. K. Dale, J. Puck, J. Davis, C. G. Hall, et al. 2002. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419: 395-409.
5. Helfer, B., B. C. Boswell, D. Finlay, A. Cipres, K. Vuori, T. Bong Kang, D. Wallach, A. Dorfleutner, J. M. Lahti, D. C. Flynn, and S. M. Frisch. 2006. Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. Cancer Res. 66: 4273-4278.
6. Saleh, M., J. P. Vaillancourt, R. K. Graham, M. Huyck, S. M. Srinivasula, E. S. Alnemri, M. H. Steinberg, V. Nolan, C. T. Baldwin, R. S. Hotchkiss, et al. 2004. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429: 75-79.
7. Nett, M. A., D. P. Cerretti, D. R. Berson, J. Seavitt, D. J. Gilbert, N. A. Jenkins, N. G. Copeland, R. A. Black, and D. D. Chaplin. 1992. Molecular cloning of the murine IL-1β converting enzyme cDNA. J. Immunol. 149: 3254-3259.
8. Casano, F. J., A. M. Rolando, J. S. Mudgett, and S. M. Molineaux. 1994. The structure and complete nucleotide sequence of the murine gene encoding interleukin-1β converting enzyme (ICE). Genomics 20: 474-481.
9. Munday, N. A., J. P. Vaillancourt, A. Ali, F. J. Casano, D. K. Miller, S. M. Molineaux, T. T. Yamin, V. L. Yu, and D. W. Nicholson. 1995. Molecular cloning and proapoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J. Biol. Chem. 270: 15870-15876.
10. Faucheu, C., A. Diu, A. W. Chan, A. M. Blanchet, C. Miossec, F. Herve, V. Collard-Dutilleul, Y. Gu, R. A. Aldape, J. A. Lippke, et al. 1995. A novel human protease similar to the interleukin-1β converting enzyme induces apoptosis in transfected cells. EMBO J. 14: 1914-1922.
11. Wang, S., M. Miura, Y. Jung, H. Zhu, V. Gagliardini, L. Shi, A. H. Greenberg, and J. Yuan. 1996. Identification and characterization of Ich-3, a member of the interleukin-1β converting enzyme (ICE)Ced-3 family and an upstream regulator of ICE. J. Biol. Chem. 271: 20580-20587.
12. Van de Craen, M., P. Vandenabeele, W. Declercq, I. Van den Brande, G. Van Loo, F. Molemans, P. Schotte, W. Van Criekinge, R. Beyaert, and W. Fiers. 1997. Characterization of seven murine caspase family members. FEBS Lett. 403: 61-69.
13. Watson, R. W., O. D. Rotstein, J. Parodo, R. Bitar, and J. C. Marshall. 1998. The IL-1β-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1β. J. Immunol. 161: 957-962.
14. Friedlander, R. M. 2003. Apoptosis and caspases in neurodegenerative diseases. N. Engl. J. Med. 348: 1365-1375.
15. Lin, X. Y., M. S. Choi, and A. G. Porter. 2000. Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-γ. J. Biol. Chem. 275: 39920-39926.
16. Ahn, E. Y., G. Pan, S. M. Vickers, and J. M. McDonald. 2002. IFN-γ upregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int. J. Cancer 100: 445-451.
17. Chawla-Sarkar, M., D. J. Lindner, Y. F. Liu, B. R. Williams, G. C. Sen, R. H. Silverman, and E. C. Borden. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249.
18. Kobori, M., Z. Yang, D. Gong, V. Heissmeyer, H. Zhu, Y. K. Jung, M. A. Gakidis, A. Rao, T. Sekine, F. Ikegami, et al. 2004. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ. 11: 123-130.
19. Schauvliege, R., J. Vanrobaeys, P. Schotte, and R. Beyaert. 2002. Caspase-11 gene expression in response to lipopolysaccharide and interferon-γ requires nuclear factor-κB and signal transducer and activator of transcription (STAT) 1. J. Biol. Chem. 277: 41624-41630.
20. Arai, H., T. Furuya, T. Yasuda, M. Miura, Y. Mizuno, and H. Mochizuki. 2004. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1β, and expression of caspase-11 in mice. J. Biol. Chem. 279: 51647-51653.
21. Hut, J., S. Y. Kim, H. Kim, S. Cha, M. S. Lee, and K. Suk. 2001. Induction of caspase-11 by inflammatory stimuli in rat astrocytes: lipopolysaccharide induction through p38 mitogen-activated protein kinase pathway. FEBS Lett. 507: 157-162.
22. Shibata, M., S. Hisahara, H. Hara, T. Yamawaki, Y. Fukuuchi, J. Yuan, H. Okano, and M. Miura. 2000. Caspases determine the vulnerability of oligodendrocytes in the ischemic brain. J. Clin. Invest. 106: 643-653.
23. Fischer, H., U. Koenig, L. Eckhart, and E. Tschachler. 2002. Human caspase 12 has acquired deleterious mutations. Biochem. Biophys. Res. Commun. 293: 722-726.
24. Saleh, M. M., J. C., M. K. Wolinski, S. J. Bensinger, P. Fitzgerald, N. Droin, R. J. Ulevitch, D. R. Green, and D. W. Nicholson. 2006. Enhanced bacterial clearance and sepsis resistance in caspase-12 deficient mice. Nature 440: 1064-1068.
25. Kalai, M., M. Lamkanfi, G. Denecker, M. Boogmans, S. Lippens, A. Meeus, W. Declercq, and P. Vandenabeele. 2003. Regulation of the expression and processing of caspase-12. J. Cell Biol. 162: 457-467.
26. Cerretti, D. P., C. J. Kozlosky, B. Mosley, N. Nelson, K. Van Ness, T. A. Greenstreet, C. J. March, S. R. Kronheim, T. Druck, L. A. Cannizzaro, et al. 1992. Molecular cloning of the intetleukin-1β converting enzyme. Science 256: 97-100.
27. Ghayur, T., S. Banerjee, M. Hugunin, D. Butler, L. Herzog, A. Carter, L. Quintal, L. Sekut, R. Talanian, M. Paskind, et al. 1997. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386: 619-623.
28. Kumar, S., C. R. Hanning, M. R. Brigham-Burke, D. J. Rieman, R. Lehr, S. Khandekar, R. B. Kirkpatrick, G. F. Scott, J. C. Lee, F. J. Lynch, et al. 2002. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-γ production. Cytokine 18: 61-71.
29. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related ptotein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
30. Kayalar, C., T. Ord, M. P. Testa, L. T. Zhong, and D. E. Bredesen. 1996. Cleavage of actin by interleukin 1β-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. USA 93: 2234-2238.
31. Beyaert, R., V. J. Kidd, S. Cornelis, M. Van de Craen, G. Denecker, J. M. Lahti, R. Gururajan, P. Vandenabeele, and W. Fiers. 1997. Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor. J. Biol. Chem. 272: 11694-11697.
32. Kahns, S., M. Kalai, L. D. Jakobsen, B. F. Clark, P. Vandenabeele, and P. H. Jensen. 2003. Caspase-1 and caspase-8 cleave and inactivate cellular parkin. J. Biol. Chem. 278: 23376-23380.
33. Kamada, S., M. Washida, J. Hasegawa, H. Kusano, Y. Funahashi, and Y. Tsujimoto. 1997. Involvement of caspase-4(-like) protease in Fas-mediated apoptotic pathway. Oncogene 15: 285-290.
34. Schwartz, S., Jr., H. Yamamoto, M. Navarro, M. Maestro, J. Reventos, and M. Perucho. 1999. Frameshift mutations at mononucleotide repears in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res. 59: 2995-3002.
35. Krippner-Heidenreich, A., R. V. Talanian, R. Sekul, R. Kraft, H. Thole, H. Ottleben, and B. Luscher. 2001. Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochem. J. 358: 705-715.
36. Kang, S. J., S. Wang, H. Hara, E. P. Peterson, S. Namura, S. Amin-Hanjani, Z. Huang, A. Srinivasan, K. J. Tomaselli, N. A. Thornberry, et al. 2000. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J. Cell Biol. 149: 613-622.
37. Kang, S. J., S. Wang, K. Kuida, and J. Yuan. 2002. Distinct downstream pathways of caspase-11 in regulating apoptosis and cytokine maturation during septic shock response. Cell Death Differ. 9: 1115-1125.
38. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10: 417-426.
39. Dinarello, C. A. 2000. Interleukin-18, a proinflammatory cytokine. Eur. Cytokine Netw. 11: 483-486.
40. Mrosovsky, N., L. A. Molony, C. A. Conn, and M. J. Kluger. 1989. Anorexic effects of interleukin 1 in the rat. Am. J. Physiol. 257: R1315-R1321.
41. Hellerstein, M. K., S. N. Meydani, M. Meydani, K. Wu, and C. A. Dinarello. 1989. Interleukin-1-induced anorexia in the rat: influence of prostaglandins. J. Clin. Invest. 84: 228-235.
42. Gatti, S., J. Beck, G. Fantuzzi, T. Bartfai, and C. A. Dinarello. 2002. Effect of interleukin-18 on mouse core body temperature. Am. J. Physiol. 282: R702-R709.
43. Dinarello, C. A. 2004. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J. Endotoxin Res. 10: 201-222.
44. Dinarello, C. A. 1984. Interleukin-1 and the pathogenesis of the acute-phase response. N. Engl. J. Med. 311: 1413-1418.
45. Stuyt, R. J., M. G. Netea, I. Verschueren, C. A. Dinarello, B. J. Kullberg, and J. W. van der Meer. 2005. Interleukin-18 does not modulate the acute-phase response. J. Endotoxin Res. 11: 85-88.
46. Samad, T. A., K. A. Moore, A. Sapirstein, S. Billet, A. Allchorne, S. Poole, J. V. Bonventre, and C. J. Woolf. 2001. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410: 471-475.
47. Strand, V., and A. F. Kavanaugh. 2004. The role of interleukin-1 in bone resorption in rheumatoid arthtitis. Rheumatology 43(Suppl. 3): iii10-iii16.
48. Voronov, E., D. S. Shouval, Y. Krelin, E. Cagnano, D. Benharroch, Y. Iwakura, C. A. Dinatello, and R. N. Apte. 2003. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. USA 100: 2645-2650.
49. Mandtup-Poulsen, T., U. Zumsteg, J. Reimers, F. Pociot, L. Morch, S. Helqvist, C. A. Dinarello, and J. Nerup. 1993. Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic β-cell destruction in insulin-dependent diabetes mellitus. Cytokine 5: 185-191.
50. Allan, S. M., P. J. Tyrrell, and N. J. Rothwell. 2005. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5: 629-640.
51. Nakamura, K., H. Okamura, M. Wada, K. Nagata, and T. Tamura. 1989. Endotoxin-induced serum factor that stimulates γ interferon production. Infect. Immun. 57: 590-595.
52. Okamura, H., H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378: 88-91.
53. Pomerantz, B. J., L. L. Reznikov, A, H. Harken, and C. A. Dinarello. 2001. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β. Proc. Natl. Acad. Sci. USA 98: 2871-2876.
54. Stuyt, R. J., M. G. Netea, T. B. Geijtenbeek, B. J. Kullberg, C. A. Dinarello, and J. W. van der Meer. 2003. Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes. Immunology 110: 329-334.
55. Netea, M. G., L. A. Joosten, E. Lewis, D. R. Jensen, P. J. Voshol, B. J. Kullberg, C. J. Tack, H. van Krieken, S. H. Kim, A. F. Stalenhoef, et al. 2006. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat. Med. 12: 650-656.
56. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267: 2000-2003.
57. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld, et al. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80: 401-411.
58. Adams, J. M., and S. Cory. 2002. Apoptosomes: engines for caspase activation. Curr. Opin. Cell Biol. 14: 715-720.
59. Tschopp, J., F. Martinon, and K. Burns. 2003. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 4: 95-104.
60. Inohara, Chamaillard, C. McDonald, and G. Nunez. 2005. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74: 355-383.
61. Murray, P. J. 2005. NOD proteins: an intracellular pathogen-recognition system or signal transduction modifiers? Curr. Opin. Immunol. 17: 352-358.
62. Agostini, L., F. Martinon, K. Burns, M. F. McDermott, P. N. Hawkins, and J. Tschopp. 2004. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325.
63. Zamboni, D. S., K. S. Kobayashi, T. Kohlsdorf, Y. Ogura, E. M. Long, R. E. Vance, K. Kuida, S. Mariathasan, V. M. Dixit, R. A. Flavell, et al. 2006. The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat. Immunol. 7: 318-325.
64. Poyet, J. L., S. M, Srinivasula, M. Tnani, M. Razmara, T. Fernandes-Alnemri, and E. S. Alnemri. 2001. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 276: 28309-28313.
65. Mariathasan, S., K. Newton, D. M. Monack, D. Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson, and V. M. Dixit. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218.
66. Mariathasan, S., D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, and V. M. Dixit. 2006. Cryopytin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
67. Kanneganti, T. D., N. Ozoren, M. Body-Malapel, A. Amer, J. H. Park, L. Franchi, J. Whitfield, W. Barchet, M. Colonna, P. Vandenabeele, et al. 2006. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440: 233-236.
68. Martinon, F., V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
69. Franchi, L., A. Amer, M. Body-Malapel, T. D. Kanneganti, N. Ozoren, R. Jagirdar, N. Inohara, P. Vandenabeele, J. Bertin, A. Coyle, et al. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages. Nat. Immunol. 7: 576-582.
70. Miao, E. A., C. M. Alpuche-Aranda, M. Dors, A. E. Clark, M. W. Bader, S. I. Miller, and A. Aderem. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nat. Immunol. 7: 569-575.
71. Humke, E. W., S. K. Shriver, M. A. Starovasnik, W. J. Fairbrother, and V. M. Dixit. 2000. ICEBERG: a novel inhibitor of interleukin-1β generation. Cell 103: 99-111.
72. Thome, M., K. Hofmann, K. Burns, F. Martinon, J. L. Bodmet, C. Mattmann, and J. Tschopp. 1998. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8: 885-888.
73. Springer, J. E., R. D. Azbill, and P. E. Knapp. 1999. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med. 5: 943-946.
74. Li, M., V. O. Ona, C. Guegan, M. Chen, V. Jackson-Lewis, L. J. Andrews, A. J. Olszewski, P. E. Stieg, J. P. Lee, S. Przedborski, and R. M. Friedlander. 2000. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288: 335-339.
75. Zhang, W. H., X. Wang, M. Narayanan, Y. Zhang, C. Huo, J. C. Reed, and R. M. Friedlander. 2003. Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc. Natl. Acad. Sci. USA 100: 16012-16017.
76. Maeda, S., L. C. Hsu, H. Liu, L. A. Bankston, M. Iimura, M. F. Kagnoff, L. Eckmann, and M. Karin. 2005. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 307: 734-738.
77. Hitomi, J., T. Katayama, Y. Eguchi, T. Kudo, M. Taniguchi, Y. Koyama, T. Manabe, S. Yamagishi, Y. Bando, K. Imaizumi, et al. 2004. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Aβ-induced cell death. J. Cell Biol. 165: 347-356.
78. Ray, C. A., R. A. Black, S. R. Kronheim, T. A. Greenstreet, P. R. Sleath, G. S. Salvesen, and D. J. Pickup. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69: 597-604.
79. Goyal, L. 2001. Cell death inhibition: keeping caspases in check. Cell 104: 805-808.
80. Young, J. L., G. K. Sukhova, D. Foster, W. Kisiel, P. Libby, and U. Schonbeck. 2000. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1β-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J. Exp. Med. 191: 1535-1544.
81. Druilhe, A., S. M. Srinivasula, M. Razmara, M. Ahmad, and E. S. Alnemri. 2001. Regulation of IL-1β generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ. 8: 649-657.
82. Lee, J., J. Hut, P. Lee, J. Y. Kim, N. Cho, S. Y. Kim, H. Kim, M. S. Lee, and K. Suk. 2001. Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells. Initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11. J. Biol. Chem. 276: 32956-32965.
83. Xue, Y., A. Daly, B. Yngvadottit, M. Liu, G. Coop, Y. Kim, P. Sabeti, Y. Chen, J. Stalker, E. Huckle, et al. 2006. Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am. J. Hum. Genet. 78: 659-670.
84. Nakagawa, T., H. Zhu, N. Morishima, E. Li, J. Xu, B. A. Yanknet, and J. Yuan. 2000. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403: 98-103.
85. Obeng, E. A., and L. H. Boise. 2005. Caspase-12 and caspase-4 are not required for caspase-dependent endoplasmic reticulum stress-induced apoptosis. J. Biol. Chem. 280: 29578-29587.
86. Di Sano, F., E. Ferraro, R. Tufi, T. Achsel, M. Piacentini, and F. Cecconi, 2006. Endoplasmic reticulum stress induces apoptosis by an apoptosome-dependent but caspase 12-independent mechanism. J. Biol. Chem. 281: 2693-2700.
87. Docke, W. D., F. Randow, U. Syrbe, D. Krausch, K. Asadullah, P. Reinke, H. D. Volk, and W. Kox. 1997. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med. 3: 678-681.
88. Vincent, J. L., Q. Sun, and M. J. Dubois. 2002. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin. Infect. Dis. 34: 1084-1093.
89. Saha, N., F. Moldovan, G. Tardif, J. P. Pelletier, J. M. Cloutier, and J, Martel-Pelletier. 1999. Interleukin-1β-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1β and interleukin-18. Arthritis Rheum. 42: 1577-1587.
90. Rudolphi, K., N. Gerwin, N. Verzijl, P. van der Kraan, and W. van den Berg. 2003. Pralnacasan, an inhibitor of interleukin-1β converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage 11: 738-746.
91. Loher, F., C. Bauer, N. Landauer, K. Schmall, B. Siegmund, H. A. Lehr, M. Dauer, M. Schoenharting, S. Endres, and A. Eigler. 2004. The interleukin-1 β-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. J. Pharmacol. Exp. Ther. 308: 583-590.
92. Stack, J. H., K. Beaumont, P. D. Larsen, K. S. Straley, G. W. Henkel, J. C. Randle, and H. M. Hoffman. 2005. IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J. Immunol. 175: 2630-2634.